Johan Häggblad

Johan Häggblad has a rich and varied work experience in the pharmaceutical industry. Johan started their career at Karo Bio AB in 1989, where they worked in the field of biochemistry and pharmacology for eight years. Johan then moved on to Pharmacia Corporation in 1997, where they continued their work in pharmacology and business development for four years. In 2001, Johann joined NeuroNova AB, where they worked in pharmacology and business development for six years. In 2007, they became the CEO of Pharmalink AB, a position they held for the next ten years. Currently, Johan is serving as the Chief Scientific Officer at Calliditas Therapeutics AB, a position they assumed in 2019, after serving as the VP of Licensing, IP & Legal for two years at the same company. Johan Häggblad's work experience demonstrates their expertise and longevity in the pharmaceutical industry.

Johan Häggblad's education history includes attending Stockholm University, New York University, University of Oxford, and University of Warwick - Warwick Business School, but no information about the years of study or degree obtained is available.